Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BDSX OTCMKTS:BRTXQ NASDAQ:EUDA OTCMKTS:PFHO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDSXBiodesix$7.60+1.3%$7.90$3.44▼$37.00$1.11B1212,103 shs191,586 shsBRTXQBioRestorative Therapies$1.54-3.8%$1.57$0.00▼$0.06$2.53B102.3662.17 million shs70,548 shsEUDAEUDA Health$1.06-7.0%$2.60$1.03▼$6.30$39.39M-0.1101,483 shs301,866 shsPFHOPacific Health Care Organization$1.17-2.5%$1.00$0.65▼$1.34$14.98M0.1314,688 shs950 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDSXBiodesix0.00%-95.75%-95.27%-93.48%-98.94%BRTXQBioRestorative Therapies0.00%-3.75%+2.67%-8.33%-8.88%EUDAEUDA Health0.00%-21.92%-55.12%-68.33%-66.57%PFHOPacific Health Care Organization0.00%+6.36%+14.71%+21.88%+40.96%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDSXBiodesix$7.60+1.3%$7.90$3.44▼$37.00$1.11B1212,103 shs191,586 shsBRTXQBioRestorative Therapies$1.54-3.8%$1.57$0.00▼$0.06$2.53B102.3662.17 million shs70,548 shsEUDAEUDA Health$1.06-7.0%$2.60$1.03▼$6.30$39.39M-0.1101,483 shs301,866 shsPFHOPacific Health Care Organization$1.17-2.5%$1.00$0.65▼$1.34$14.98M0.1314,688 shs950 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDSXBiodesix0.00%-95.75%-95.27%-93.48%-98.94%BRTXQBioRestorative Therapies0.00%-3.75%+2.67%-8.33%-8.88%EUDAEUDA Health0.00%-21.92%-55.12%-68.33%-66.57%PFHOPacific Health Care Organization0.00%+6.36%+14.71%+21.88%+40.96%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBDSXBiodesix 2.80Moderate Buy$35.00360.53% UpsideBRTXQBioRestorative Therapies 0.00N/AN/AN/AEUDAEUDA Health 4.00Strong BuyN/AN/APFHOPacific Health Care Organization 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBDSXBiodesix$71.32M15.63N/AN/A$0.14 per share54.29BRTXQBioRestorative Therapies$110K22,954.76N/AN/A($0.68) per share-2.26EUDAEUDA Health$4.01M9.82N/AN/A($0.07) per share-15.14PFHOPacific Health Care Organization$6.07M2.47$0.07 per share16.31$0.91 per share1.29Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBDSXBiodesix-$42.93M-$0.29N/AN/AN/A-53.66%-269.67%-43.94%11/7/2025 (Estimated)BRTXQBioRestorative Therapies-$12.52M-$1.07N/A∞N/AN/AN/AN/AN/AEUDAEUDA Health-$15.36MN/A0.00N/AN/AN/AN/AN/AN/APFHOPacific Health Care Organization$880K$0.1011.70∞N/A21.18%11.76%11.09%10/30/2025 (Estimated)Latest PFHO, BDSX, BRTXQ, and EUDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025BDSXBiodesix-$1.40-$1.60-$0.20-$0.08$18.47 million$20.02 million7/31/2025Q2 2025PFHOPacific Health Care OrganizationN/A$0.05N/A$0.05N/A$1.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBDSXBiodesixN/AN/AN/AN/AN/ABRTXQBioRestorative TherapiesN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/APFHOPacific Health Care OrganizationN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBDSXBiodesix41.112.142.14BRTXQBioRestorative TherapiesN/AN/AN/AEUDAEUDA HealthN/A0.180.15PFHOPacific Health Care OrganizationN/A18.9418.94Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBDSXBiodesix20.96%BRTXQBioRestorative TherapiesN/AEUDAEUDA Health4.35%PFHOPacific Health Care OrganizationN/AInsider OwnershipCompanyInsider OwnershipBDSXBiodesix30.10%BRTXQBioRestorative Therapies12.20%EUDAEUDA HealthN/APFHOPacific Health Care Organization61.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBDSXBiodesix220146.63 million102.50 millionOptionableBRTXQBioRestorative Therapies71.64 billionN/ANot OptionableEUDAEUDA Health237.16 millionN/ANot OptionablePFHOPacific Health Care Organization3012.80 million4.92 millionNot OptionablePFHO, BDSX, BRTXQ, and EUDA HeadlinesRecent News About These CompaniesFormer CFO who embezzled $211K from health care funds sentencedSeptember 4, 2025 | msn.comPacific Health Care Organization Board RestructuringAugust 14, 2025 | msn.comPacific Health Care Organization, Inc. Reports its Second Quarter 2025 Financial ResultsJuly 31, 2025 | globenewswire.comChile joins PAHO-led Alliance to strengthen primary health care systemsMay 26, 2025 | msn.comPacific Health Care Organization, Inc. Reports its First Quarter 2025 Financial ResultsMay 2, 2025 | globenewswire.comPAHO insists on the importance of universal access to careApril 20, 2025 | en.mercopress.comEPAHO warns of increase in yellow fever casesMarch 27, 2025 | cidrap.umn.eduCPAHO warns of NCDs spreading in the regionMarch 27, 2025 | en.mercopress.comEPacific Health Care Organization, Inc. Reports its 2024 Year-End Financial ResultsMarch 19, 2025 | globenewswire.comPAHO is Latin America's Centre for Disease Control and PreventionMarch 1, 2025 | thelancet.comTDespite WHO exit plan, US still in Americas health agencyFebruary 27, 2025 | reuters.comIn PAHO-backed access initiative, Argentina's Sinergium Biotech to locally produce Pfizer's Prevnar 20January 16, 2025 | fiercepharma.comFASPPH Applauds Milestone Collaboration Between PAHO and WHO AcademyJanuary 8, 2025 | aspph.orgAHawaii Pacific Health's four-step approach to training leadersNovember 9, 2024 | bizjournals.comWaipahu High School offers hands-on health care trainingNovember 8, 2024 | bizjournals.comPacific Health Care Organization, Inc. Reports its Third Quarter 2024 ResultsNovember 5, 2024 | globenewswire.comProvidence to outsource home health, hospice services to private equity-backed CompassusOctober 25, 2024 | oregonlive.comOHow Asian Americans are filling the gaps in care for their elderly parentsOctober 22, 2024 | pbs.orgPDignity Health hones in on creating large cardiovascular groupOctober 19, 2024 | pacbiztimes.comPMetro Pacific Health, mWell ink referral partnershipOctober 18, 2024 | bworldonline.comBNew MarketBeat Followers Over TimeMedia Sentiment Over TimePFHO, BDSX, BRTXQ, and EUDA Company DescriptionsBiodesix NASDAQ:BDSX$7.60 +0.10 (+1.31%) Closing price 04:00 PM EasternExtended Trading$7.60 0.00 (-0.07%) As of 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.BioRestorative Therapies OTCMKTS:BRTXQ$1.54 -0.06 (-3.75%) As of 09/12/2025BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders. The BRTX-100 utilizes proprietary technology and involves collecting a patient's bone marrow, isolating and culturing stem cells from the bone marrow, and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient's damaged disc and treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. The company have received authorization from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100to treat persistent lower back pain due to painful degenerative discs. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy in preclinical stage to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). In addition, the company provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; and a research agreement with Pfizer, Inc. and the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York. On March 20, 2020, BioRestorative Therapies, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of New York.EUDA Health NASDAQ:EUDA$1.06 -0.08 (-7.02%) Closing price 03:59 PM EasternExtended Trading$1.07 +0.01 (+0.94%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.Pacific Health Care Organization OTCMKTS:PFHO$1.17 -0.03 (-2.50%) As of 09/12/2025 03:46 PM EasternPacific Health Care Organization, Inc., together with its subsidiaries, operates as a specialty workers' compensation cost containment company in the United States. It is involved in managing and administering health care organizations (HCOs) and medical provider networks (MPNs). The company also provides claims-related services, including utilization review, medical case management, medical bill review, employee advocate services, workers' compensation carve-outs, expert witness testimony, and Medicare set-aside services. It serves insurers, third party administrators, self-administered employers, municipalities, and other industries. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Irvine, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir’s Commercial Growth Story Is Just Getting Started The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Royal Caribbean's 33% Dividend Hike Signals Deeper Growth MarketBeat Week in Review – 09/08 - 09/12 Adobe’s Rebound Has Room to Run: 25% Upside by Year-End Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
